Join us at AES 2021

Skip to main content
NeuroPace, Inc
  • Patients
  • Providers
  • Corporate
  • Investors
  • nSight
  • PDMS
  • Take the Quiz
  • Clinical Trials
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Preliminary NAUTILUS Results
  • Hear from Patients
    • Patient Stories
    • How Data Helped
    • RNS Community Chat
  • Resources
    • Find a Center
    • RNS Community Chat
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Clinical Trials
    • Contact Us
  • Blog
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Preliminary NAUTILUS Results
  • Hear from Patients
    • Patient Stories
    • How Data Helped
    • RNS Community Chat
  • Resources
    • Find a Center
    • RNS Community Chat
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Clinical Trials
    • Contact Us
  • Blog
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
Press enter to begin your search
neuropace logo

Join Us at AES 2021

December 3–7 | Chicago, IL

The New
nSight Platform

NeuroPace’s new nSight Platform gives you concise reports that integrate RNS® System data, patient reported outcomes, and programming references to help you provide personalized, data-driven care to your patients.

Get a hands-on demonstration at booth #818
RNS Tablet
The New
nSight Platform

NeuroPace’s new nSight Platform gives you concise reports that integrate RNS® System data, patient reported outcomes, and programming references to help you provide personalized, data-driven care to your patients.

Get a hands-on demonstration at booth #818

NeuroPace Events at AES

Fellows Networking Reception

Insights Gained from the RNS® System

Featuring
Dr. Ambica Tumkur and Dr. Vikram Rao

Friday, Dec. 3 from 6:00 – 8:00 pm

Register Here

restaurant

Programming Workshops

Saturday, December 4 – Monday, December 6
(60 minute workshops*)

Join us for an online RNS System Programming Session to find out how actionable, data-driven insights can be used to optimize therapy settings, manage AEDs, and support remote patient management.

This course will provide hands-on training with the RNS Tablet, Patient Data Management System, and the newly launched nSight Platform. Walk through the programming steps involved in follow-up appointments, from initial visit to therapy optimization over time.

Register Here
*60 minutes hands-on session with an additional 30 minutes reserved for optional training

RNS tablet

Come Visit Us!

Pop by Booth #818 in the Exhibit Hall

Saturday, December 4 – Monday, December 6

Speak with our Scientists in Innovation Pavilion D

Hear about the latest data insights and clinical outcomes and view scientific posters related to brain-responsive neuromodulation.

AES booth

Check out the latest research and clinical experiences with the RNS® System

Select Poster Sessions

MRI-guided laser therapy for refractory focal epilepsy in a patient with a fully implanted RNS System

Vivek Buch, MD (primary), Emily Mirro, David Purger, MD, Michael Zeineh, MD, PhD, Babak Razavi, MD, PhD, Casey Halpern, MD

Replacement of RNS System orthogonal with longitudinal mesial temporal depth electrodes leading to shifting lateralization of ECoG epileptiform activity: A case report

Gamaleldin M. Osman, MD (primary), Melinda M. Marthaler, Cindy M. Nelson,R EEG T, Nicholas M. Gregg, MD, Kai J. Miller, MD, PhD, Brian N. Lundstrom, MD, PhD

Correlation of Post Ictal EcoG Suppression With Seizure Patterns in RNS System Patients

Rabia Yasin MBBS (primary), Kenneth Ndyabawe PhD, Trishna Kantamneni MD, Kiran Kanth MD, Katherine Park MD1 Merit Vick, Emily Mirro, Jeffrey Kennedy MD

Responsive Neurostimulation in Patients with Seizure Relapse after Epilepsy Surgery

Navya Joseph (primary), Navnika Gupta, Daniel Zhou, Arun Sebastian, Tyler Mackey, Olga Taraschenko & Proleta Datta

Use of a novel Artificial Intelligence therapy proposer on two non-responding patients treated with the RNS System

Stephanie H. Chen, MD, MS (primary), Lesley Kaye, MD, Sharanya Desai, Tiara Monroe Smith, Merit Vick

Long-term intracranial EEG lateralization of epileptogenicity in patients that have confirmed or suspected bilateral mesial temporal lobe onsets during epilepsy surgical evaluation

Amir M. Arain (primary), Emily A. Mirro, Dan Brown, Angela Peters, Blake Newman, Sindhu Richards, John D. Rolston

Cross-patient similar iEEG search

Sharanya Desai (primary), Thomas Tcheng, Martha Morrell

MR Imaging with the brain-responsive neurostimulator system: A Case-Based Report

David Burdette (primary), Mark DeLano, David Greene

Use of the NeuroPace RNS System at a Level 4 Academic Center

Elliot Neal MD (primary) , Lionel Dacpano , Stephanie MacIver MD, Angelica Rivera-Cruz MD, Ushtar Amin MD, Selim Benbadis MD, Yerema Bezchlibnyk MD PhD

Low frequency stimulation in patients with responsive neurostimulation

Juan Luis Alcala-Zermeno, MD, Melinda Marthaler Cindy Nelson R. EEG T., Gamaleldin Osman M.B.B.Ch., Richard Marsh MD, Jamie J. Van Gompel, MD, Kai J. Miller MD PhD Gregory A. Worrell, MD, PhD, Nicholas M. Gregg, MD Brian N. Lundstrom, MD, PhD

Learning to Generalize Seizure Forecasting

Marc G. Leguia, Timothée Proix, Thomas K. Tcheng, Vikram R. Rao, & Maxime O. Baud

Effect of pharmacotherapy on multidien cycles of seizures in focal epilepsy

Cecilia Friedrichs-Maeder, Tara Skarpaas, Thomas K. Tcheng, Vikram R. Rao, Maxime O. Baud

  • Safety Information
  • Legal
  • Privacy Policy
1-866-726-387624-hr Support Line

PATIENTS

  • Drug-Resistant Epilepsy
  • The RNS System
  • Hear from Patients
  • Is It Right for You?
  • Current Patients
  • Resources

PROVIDERS

  • Product
  • Clinical Benefits
  • Actionable Insights
  • Patient Selection
  • Education & Training
  • Resources

CORPORATE

  • In The News
  • Press Releases
  • Leadership
  • Careers
  • Contact Us
  • FCOI Procedure
  • PATIENTS

    Safety
  • PROVIDERS

    Legal
  • INVESTORS

    Privacy Policy
  • CORPORATE

1-866-726-3876 24-hr Support Line

© 2026 NeuroPace, Inc.

Step 1 of 7

14%
    The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.
  • Based on your answers, your patient might benefit from the RNS System.

    Get your profile and a list of questions to ask your doctor.

  • Unfortunately it appears your patient is not an appropriate candidate for the RNS® System at this time.

  • The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

    If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.

  • If you are interested in learning more about the RNS® System, you can have an RNS® System professional contact you by filling out the form below:

  • By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

    By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

    * Required fileds

Share your Story: Terms and conditions

By filling out the form and submitting your story (and/or photograph), you are agreeing to the following:

  1. NeuroPace may review the information and any photographs you provide for potential publication on our website.
  2. If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn. Unless you sign the release, we will not publish the story, your name, or the photographs you provided.
  3. Regardless of whether we publish your story, we will add your name and e-mail address to the NeuroPace email list to hear from us about product updates, upcoming events and other relevant information. We will not sell your information to third parties. 
  4. Our use of your information is subject to our Privacy Policy, which you can access here.
neuropace logoLogo Header Menu
  • Patients
  • Providers
  • Corporate
  • Investors
  • nSight
  • PDMS
  • Take the Quiz
  • Clinical Trials